As of 2025-05-21, the EV/EBITDA ratio of Boill Healthcare Holdings Ltd (1246.HK) is -3.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 1246.HK's latest enterprise value is 870.22 mil HKD. 1246.HK's TTM EBITDA according to its financial statements is -248.83 mil HKD. Dividing these 2 quantities gives us the above 1246.HK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 11.8x | 6.2x |
| Forward P/E multiples | 4.4x - 8.2x | 6.2x |
| Fair Price | (1.59) - (2.13) | (1.75) |
| Upside | -7693.4% - -10241.2% | -8439.4% |
| Date | EV/EBITDA |
| 2025-04-30 | -3.50 |
| 2025-04-29 | -3.50 |
| 2025-04-28 | -3.50 |
| 2025-04-25 | -3.50 |
| 2025-04-24 | -3.50 |
| 2025-04-23 | -3.50 |
| 2025-04-22 | -3.50 |
| 2025-04-17 | -3.50 |
| 2025-04-16 | -3.50 |
| 2025-04-15 | -3.50 |
| 2025-04-14 | -3.50 |
| 2025-04-11 | -3.50 |
| 2025-04-10 | -3.50 |
| 2025-04-09 | -3.50 |
| 2025-04-08 | -3.50 |
| 2025-04-07 | -3.50 |
| 2025-04-03 | -3.50 |
| 2025-04-02 | -3.50 |
| 2025-04-01 | -3.50 |
| 2025-03-31 | -3.50 |
| 2025-03-28 | -3.50 |
| 2025-03-27 | -3.50 |
| 2025-03-26 | -3.50 |
| 2025-03-25 | -3.50 |
| 2025-03-24 | -3.50 |
| 2025-03-21 | -3.50 |
| 2025-03-20 | -3.50 |
| 2025-03-19 | -3.50 |
| 2025-03-18 | -3.50 |
| 2025-03-17 | -3.50 |
| 2025-03-14 | -3.50 |
| 2025-03-13 | -3.50 |
| 2025-03-12 | -3.50 |
| 2025-03-11 | -3.50 |
| 2025-03-10 | -3.50 |
| 2025-03-07 | -3.50 |
| 2025-03-06 | -3.50 |
| 2025-03-05 | -3.50 |
| 2025-03-04 | -3.50 |
| 2025-03-03 | -3.50 |
| 2025-02-28 | -3.50 |
| 2025-02-27 | -3.50 |
| 2025-02-26 | -3.50 |
| 2025-02-25 | -3.50 |
| 2025-02-24 | -3.50 |
| 2025-02-21 | -3.50 |
| 2025-02-20 | -3.50 |
| 2025-02-19 | -3.50 |
| 2025-02-18 | -3.50 |
| 2025-02-17 | -3.50 |